Relevant bibliographies by topics / Cardiovascular screening / Journal articles

Journal articles on the topic 'Cardiovascular screening'

To see the other types of publications on this topic, follow the link: Cardiovascular screening.
Author: Grafiati
Published: 19 May 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cardiovascular screening.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Thompson, Paul D., and Carl Sherman. "Cardiovascular Screening." Physician and Sportsmedicine 24, no. 6 (June 1996): 47–106. http://dx.doi.org/10.3810/psm.1996.06.1375.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thompson, Paul D., and Carl Sherman. "Cardiovascular Screening." Physician and Sportsmedicine 24, no. 6 (June 1996): 47–106. http://dx.doi.org/10.1080/00913847.1996.11947967.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Herbert, David L. "Preparticipation Cardiovascular Screening." Physician and Sportsmedicine 25, no. 3 (March 1997): 112–17. http://dx.doi.org/10.3810/psm.1997.03.1242.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Duffy, Jennifer Y., and Afshan B. Hameed. "Cardiovascular disease screening." Seminars in Perinatology 39, no. 4 (June 2015): 264–67. http://dx.doi.org/10.1053/j.semperi.2015.05.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Seto, Craig K. "Preparticipation cardiovascular screening." Clinics in Sports Medicine 22, no. 1 (January 2003): 23–35. http://dx.doi.org/10.1016/s0278-5919(02)00040-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bierig, S. Michelle, Anita Arnold, Lynne C. Einbinder, Eric Armbrecht, and Thomas Burroughs. "Cardiovascular Ultrasound Combined With Non-invasive Screening for the Detection of Undiagnosed Cardiovascular Disease: A Literature Review." Journal of Diagnostic Medical Sonography 34, no. 3 (November 24, 2017): 197–206. http://dx.doi.org/10.1177/8756479317737764.

Full text
Abstract:
Non-invasive screenings have been widely utilized in the United States and worldwide to provide early identification of cardiovascular disease, allowing for earlier diagnosis and treatment. Screening sonography detects valve disease, cardiac dysfunction, and carotid disease in 5% to 20% of the population. This review discusses the current data regarding cardiovascular screening, the methodologies, and the resources required for performance of screenings. Cardiac and carotid sonography is highly accurate and discovers cardiovascular diseases that impact quality of life and risk of future events. Screenings are performed in a variety of settings and accuracy depends on the quality of personnel performing the non-invasive testing, the equipment utilized, and the personnel interpreting the studies. Despite the potential benefit for disease detection, population screening to detect cardiovascular disease is not widely supported by national organizations due to the theoretical cost of further testing and lack of cost versus benefit data. Additional studies are necessary to compare costs and benefits of non-invasive cardiovascular screening in the community setting.
APA, Harvard, Vancouver, ISO, and other styles
7

Bierig, S. Michelle, Anita Arnold, Lynne C. Einbinder, Eric Armbrecht, and Thomas Burroughs. "Unrecognized Cardiovascular Abnormalities Detected Through a Community Cardiovascular Screening Program." Journal of Diagnostic Medical Sonography 36, no. 3 (March 16, 2020): 234–42. http://dx.doi.org/10.1177/8756479320905836.

Full text
Abstract:
Objective: Self-referral community cardiovascular screening programs (CCSPs) have a potential to reduce outcome events through early detection of disease. This study evaluated the characteristics of a population that could predict a positive test. Materials and Methods: Participants who completed a cardiovascular screening protocol were compared. The screening protocol included a blood pressure (BP), Doppler ankle brachial index (ABI) testing, a limited carotid sonogram, a limited aortic sonogram, electrocardiogram (ECG), and limited transthoracic echocardiogram (TTE). Results: Screenings were performed on 205 participants (58% female, 68 ± 9 years of age). Sixty-seven (34%) participants were abnormal in at least one of the following screening tests: ABI (2%), carotid sonogram (6%), aortic sonogram (3%), ECG (11%), and TTE (22%). Although 60.5% of the participants reported recent symptoms, there were no differences in normal or abnormal results of participants presenting with or without symptoms ( P = .06). Income was not a predictor of abnormal test results (odds ratio, 0.76; 95% confidence interval, 0.55–0.97; P = .19). Multivariate analysis demonstrated, when controlling for age greater than 75 years, that participants taking BP medication was the only variable that predicted a positive test result. Conclusion: One-third of patient results were abnormal, regardless of symptoms or lack thereof, suggestive of subclinical disease. Further large-scale studies would demonstrate the role of CCSPs in risk stratifying participants.
APA, Harvard, Vancouver, ISO, and other styles
8

Takahashi, Atsuhiko, and Toshio Kushiro. "Update cardiovascular screening methods." Health Evaluation and Promotion 38, no. 6 (2011): 737–43. http://dx.doi.org/10.7143/jhep.38.737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yoshinaga, Masao. "School-Based Cardiovascular Screening." Pediatric Cardiology and Cardiac Surgery 29, no. 5 (2013): 212–17. http://dx.doi.org/10.9794/jspccs.29.212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kim, Yong-Lim. "Cardiovascular Screening before Transplantation." Journal of the Korean Society for Transplantation 25, no. 4 (2011): 225. http://dx.doi.org/10.4285/jkstn.2011.25.4.225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Berg, John Erik. "Screening for cardiovascular risk." Journal of Cardiovascular Risk 2, no. 5 (October 1995): 441???448. http://dx.doi.org/10.1097/00043798-199510000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Stajic, Zoran, and Zdravko Mijailovic. "Cardiovascular screening of athletes." Vojnosanitetski pregled 66, no. 12 (2009): 1005–9. http://dx.doi.org/10.2298/vsp0912005s.

Full text
Abstract:
<Zakljucak> Sprovodjenje kardiovaskularnog skrining programa ima za cilj smanjenje ucestalosti iznenadne srcane smrti kod sportista. Potrebno je doneti nacionalne preporuke koje bi trebalo da jasno definisu obim, organizaciju i sprovodjenje skrininga i redovnih sistematskih pregleda sportista. U medjuvremenu, dok se ne donesu posebne nacionalne preporuke, smatramo da je neophodno da se svi klinicki lekari koji se bave sportskom medicinom detaljno upoznaju sa vazecim evropskim i americkim preporukama, a za prakticnu primenu u svakodnevnoj rutinskoj klinickoj praksi predlazemo primenu modifikovanog americko-evropskog skrining programa koji bi se sastojao od 12 tacaka iz americkih preporuka (navedeno u tabeli 2) i obaveznog 12- kanalnog EKG-a.
APA, Harvard, Vancouver, ISO, and other styles
13

Frolkis, Joseph P. "SCREENING FOR CARDIOVASCULAR DISEASE." Medical Clinics of North America 83, no. 6 (November 1999): 1339–73. http://dx.doi.org/10.1016/s0025-7125(05)70170-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Mou, Margaret, and Don P. Wilson. "Cardiovascular Screening in Youth*†." Journal of Clinical Lipidology 9, no. 3 (May 2015): 443–44. http://dx.doi.org/10.1016/j.jacl.2015.03.055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Beckerman, James, Paul Wang, and Mark Hlatky. "Cardiovascular Screening of Athletes." Clinical Journal of Sport Medicine 14, no. 3 (May 2004): 127–33. http://dx.doi.org/10.1097/00042752-200405000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

WIERZBICKI, A. "Screening for cardiovascular disease." European Heart Journal 25, no. 11 (June 2004): 996. http://dx.doi.org/10.1016/j.ehj.2004.02.031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Maron, Barry J., Bo Gregers Winkel, and Jacob Tfelt-Hansen. "Perspectives on Cardiovascular Screening." JAMA 313, no. 1 (January 6, 2015): 31. http://dx.doi.org/10.1001/jama.2014.16253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Gupta, Sanjaya, Timir Baman, and Sharlene M. Day. "Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening." Sports Health: A Multidisciplinary Approach 1, no. 6 (November 2009): 500–507. http://dx.doi.org/10.1177/1941738109350405.

Full text
Abstract:
Context: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of an electrocardiogram as a screening implement has provoked international controversy. Evidence acquisition: Part 1 of this review highlights the current guidelines and controversies surrounding cardiovascular screening, with a focus on the diagnostic challenges associated with identifying athletes with inheritable cardiomyopathies. Data sources were limited to peer-reviewed publications from 1984 to the present. Results: Preparticipation screening should include at least a history and a physical examination for all athletes, whereas use of an electrocardiogram is still controversial. Diagnosis of inherited cardiomyopathies presents unique challenges, particularly in hypertrophic cardiomyopathy, where many features can mimic those found in the “athlete’s heart.” Conclusions: Recognizing cardiac conditions in athletes that can predispose them to sudden cardiac death or other adverse outcomes is of vital importance, as is the appropriate exclusion of these athletes from competition. Further studies are needed to determine the most efficient and cost-effective means of screening and to increase the sensitivity and specificity of diagnostic testing for inheritable cardiovascular diseases.
APA, Harvard, Vancouver, ISO, and other styles
19

Gonzales, Boris, Miguel Ángel Bayo, Carmen Garcia, Laura García Serrano, Sara Sánchez Giralt, Juan Manuel Nogales, Sergio Barroso, Enrique Luna, and Emilio Sánchez Casado. "Screening cardiovascular pretrasplante y riesgo cardiovascular postrasplante." Diálisis y Trasplante 36, no. 2 (July 2015): 61–62. http://dx.doi.org/10.1016/j.dialis.2015.04.033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kóródi, Gyula. "Health Screening Examinations in Cardiovascular Risk Estimation." Academic and Applied Research in Military and Public Management Science 12, no. 1 (June 30, 2013): 39–43. http://dx.doi.org/10.32565/aarms.2013.1.4.

Full text
Abstract:
The most important elements in prevention of cardiovascular (and cerebrovascular) dis- eases are screening and managing the risk factors, such as high blood pressure, high total cholesterol or high blood glucose etc.. The best way to find out the personal specific risk profile is through screening tests during annual doctor visits. Regular cardiovascu- lar and cerebrovascular screenings are very important because they help detect the risk factors in their earliest and asymptomatic stages. This way, the patients can treat their risk factors with lifestyle changes and pharmacotherapies, if appropriate, before it ulti- mately leads to the development of cardiovascular disease. For many patients, screening results can serve as a wake-up call. When the regular test comes back and the patient sees and understands the abnormal parameters, it becomes extremely personal. The idea of making lifestyle changes is not just a recommendation in a pamphlet; it is something that can impact the patient’s whole life, habits and health. The best way for optimal health benefits is through regular cardiovascular screening tests beginning at age 20. Because of very high cardiovascular morbidity and mortality, early and regular screen- ings could be a basic element of preventive health care.
APA, Harvard, Vancouver, ISO, and other styles
21

Asif, Irfan M., and Jonathan A. Drezner. "Cardiovascular Screening in Young Athletes." Current Sports Medicine Reports 15, no. 2 (March 2016): 76–80. http://dx.doi.org/10.1249/jsr.0000000000000247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Hamel, Leslie, and Kathleen Oberle. "Cardiovascular Risk Screening for Women." Clinical Nurse Specialist 10, no. 6 (November 1996): 275–79. http://dx.doi.org/10.1097/00002800-199611000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

SHERMAN-BROWN, ALICE, and AFSHAN B. HAMEED. "Cardiovascular Disease Screening in Pregnancy." Clinical Obstetrics & Gynecology 63, no. 4 (October 13, 2020): 808–14. http://dx.doi.org/10.1097/grf.0000000000000565.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Siddiqui, Saad, and Dilip R. Patel. "Cardiovascular Screening of Adolescent Athletes." Pediatric Clinics of North America 57, no. 3 (June 2010): 635–47. http://dx.doi.org/10.1016/j.pcl.2010.03.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Dadlani, Gul H., Coralis Mercado, Val Roberts, Holiday Blackwelder, Kaye Erickson, Gabrielle Shrimpton, Jennifer Stein, et al. "Cardiovascular screening in Williams syndrome." Progress in Pediatric Cardiology 58 (September 2020): 101267. http://dx.doi.org/10.1016/j.ppedcard.2020.101267.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Steinberger, Julia. "School screening for cardiovascular risk." Journal of Pediatrics 208 (May 2019): 1–2. http://dx.doi.org/10.1016/j.jpeds.2019.03.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Sigler, M., T. Paul, and R. G. Grabitz. "Biocompatibility screening in cardiovascular implants." Zeitschrift für Kardiologie 94, no. 6 (June 2005): 383–91. http://dx.doi.org/10.1007/s00392-005-0231-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Guthrie, B. "Screening for cardiovascular risk factors." BMJ 307, no. 6895 (July 3, 1993): 65. http://dx.doi.org/10.1136/bmj.307.6895.65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Smolderen, Kim G., Annelies E. Aquarius, and Johan Denollet. "Depression and Screening Cardiovascular Events." Journal of General Internal Medicine 23, no. 9 (July 16, 2008): 1543. http://dx.doi.org/10.1007/s11606-008-0696-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

EMPANA, J. "Screening for cardiovascular disease: reply." European Heart Journal 25, no. 11 (June 2004): 996–97. http://dx.doi.org/10.1016/j.ehj.2004.02.032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Drezner, Jonathan A., Jordan M. Prutkin, Kimberly G. Harmon, John W. O’Kane, Hank F. Pelto, Ashwin L. Rao, Jeffrey D. Hassebrock, et al. "Cardiovascular Screening in College Athletes." Journal of the American College of Cardiology 65, no. 21 (June 2015): 2353–55. http://dx.doi.org/10.1016/j.jacc.2015.02.072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Harmon, Kimberly G., and Jonathan A. Drezner. "Cardiovascular Screening for Young Athletes." JAMA 313, no. 16 (April 28, 2015): 1673. http://dx.doi.org/10.1001/jama.2015.3231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Niebauer, Josef, Domenico Corrado, and Antonio Pelliccia. "Cardiovascular Screening for Young Athletes." JAMA 313, no. 16 (April 28, 2015): 1674. http://dx.doi.org/10.1001/jama.2015.3234.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Lagerweij, GR, L. Brouwers, GA De Wit, KGM Moons, L. Benschop, AHEM Maas, A. Franx, et al. "Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia: A micro-simulation study." European Journal of Preventive Cardiology 27, no. 13 (February 13, 2020): 1389–99. http://dx.doi.org/10.1177/2047487319898021.

Full text
Abstract:
Background Preeclampsia is a female-specific risk factor for the development of future cardiovascular disease. Whether early preventive cardiovascular disease risk screenings combined with risk-based lifestyle interventions in women with previous preeclampsia are beneficial and cost-effective is unknown. Methods A micro-simulation model was developed to assess the life-long impact of preventive cardiovascular screening strategies initiated after women experienced preeclampsia during pregnancy. Screening was started at the age of 30 or 40 years and repeated every five years. Data (initial and follow-up) from women with a history of preeclampsia was used to calculate 10-year cardiovascular disease risk estimates according to Framingham Risk Score. An absolute risk threshold of 2% was evaluated for treatment selection, i.e. lifestyle interventions (e.g. increasing physical activity). Screening benefits were assessed in terms of costs and quality-adjusted-life-years, and incremental cost-effectiveness ratios compared with no screening. Results Expected health outcomes for no screening are 27.35 quality-adjusted-life-years and increase to 27.43 quality-adjusted-life-years (screening at 30 years with 2% threshold). The expected costs for no screening are €9426 and around €13,881 for screening at 30 years (for a 2% threshold). Preventive screening at 40 years with a 2% threshold has the most favourable incremental cost-effectiveness ratio, i.e. €34,996/quality-adjusted-life-year, compared with other screening scenarios and no screening. Conclusions Early cardiovascular disease risk screening followed by risk-based lifestyle interventions may lead to small long-term health benefits in women with a history of preeclampsia. However, the cost-effectiveness of a lifelong cardiovascular prevention programme starting early after preeclampsia with risk-based lifestyle advice alone is relatively unfavourable. A combination of risk-based lifestyle advice plus medical therapy may be more beneficial.
APA, Harvard, Vancouver, ISO, and other styles
35

Wen, Dennis Y. "Preparticipation Cardiovascular Screening of Young Athletes." Physician and Sportsmedicine 32, no. 6 (June 2004): 23–30. http://dx.doi.org/10.3810/psm.2004.06.387.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Wen, Dennis Y. "Preparticipation Cardiovascular Screening off Young Athletes." Physician and Sportsmedicine 33, no. 12 (December 2005): 31–42. http://dx.doi.org/10.3810/psm.2005.12.274.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

&NA;. "Cardiovascular Preparticipation Screening of Competitive Athletes." Medicine &amp Science in Sports &amp Exercise 28, no. 12 (December 1996): 1445–52. http://dx.doi.org/10.1097/00005768-199612000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Barker, D., S. Barber, KM Birch, and LB Tan. "Cardiovascular screening of asymptomatic postmenopausal women." European Journal of Cardiovascular Prevention & Rehabilitation 13, Supplement 1 (May 2006): S65—S66. http://dx.doi.org/10.1097/00149831-200605001-00265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Panhuyzen-Goedkoop, N. M. "Preparticipation cardiovascular screening in young athletes." British Journal of Sports Medicine 43, no. 9 (September 1, 2009): 629–30. http://dx.doi.org/10.1136/bjsm.2009.064220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Asif, Irfan M., Jonathan A. Drezner, and Francis G. O’Connor. "Cardiovascular Preparticipation Screening in Young Athletes." Sports Health: A Multidisciplinary Approach 9, no. 1 (December 16, 2016): 19–21. http://dx.doi.org/10.1177/1941738116680188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Bultas, Margaret W. "Understanding Sports Preparticipation Cardiovascular Screening Recommendations." NASN School Nurse 27, no. 6 (July 24, 2012): 318–22. http://dx.doi.org/10.1177/1942602x12453336.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Maron, Barry J., Paul D. Thompson, James C. Puffer, Christopher A. McGrew, William B. Strong, Pamela S. Douglas, Luther T. Clark, et al. "Cardiovascular Preparticipation Screening of Competitive Athletes." Circulation 94, no. 4 (August 15, 1996): 850–56. http://dx.doi.org/10.1161/01.cir.94.4.850.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Zão, Ana, Sandra Magalhães, and Mário Santos. "Frailty in cardiovascular disease: Screening tools." Revista Portuguesa de Cardiologia (English Edition) 38, no. 2 (February 2019): 143–58. http://dx.doi.org/10.1016/j.repce.2018.05.016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Sullivan, David R. "Screening for cardiovascular disease with cholesterol." Clinica Chimica Acta 315, no. 1-2 (January 2002): 49–60. http://dx.doi.org/10.1016/s0009-8981(01)00720-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Zão, Ana, Sandra Magalhães, and Mário Santos. "Frailty in cardiovascular disease: Screening tools." Revista Portuguesa de Cardiologia 38, no. 2 (February 2019): 143–58. http://dx.doi.org/10.1016/j.repc.2018.05.019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Jurkowski, Janine M. "Nativity and Cardiovascular Disease Screening Practices." Journal of Immigrant and Minority Health 8, no. 4 (May 27, 2006): 339–46. http://dx.doi.org/10.1007/s10903-006-9004-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Morris, Charles K., and Victor F. Froelicher. "Cardiovascular Screening for High Altitude Trekking." Clinical Journal of Sport Medicine 1, no. 2 (April 1991): 100–103. http://dx.doi.org/10.1097/00042752-199104000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Seto, Craig K., and Michael E. Pendleton. "Preparticipation Cardiovascular Screening in Young Athletes." Current Sports Medicine Reports 8, no. 2 (March 2009): 59–64. http://dx.doi.org/10.1249/jsr.0b013e31819ccdaf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Maron, Barry J., Bo Gregers Winkel, and Jacob Tfelt-Hansen. "Cardiovascular Screening for Young Athletes—Reply." JAMA 313, no. 16 (April 28, 2015): 1674. http://dx.doi.org/10.1001/jama.2015.3237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Carek, P. J. "Cardiovascular Screening of High School Athletes." JAMA: The Journal of the American Medical Association 281, no. 7 (February 17, 1999): 607–8. http://dx.doi.org/10.1001/jama.281.7.607.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Cardiovascular screening' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography